Key result
TSC/MTOR-associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May warrant molecular testing in atypical eosinophilic renal tumors; leaves open prospective validation of diagnostic and prognostic criteria.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kiril Trpkov (2023) studied this question. TSC/MTOR-associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum.
Synapse has enriched 10 related papers. Consider them for comparative context: